Page 14 of presentation at the conference - in the last 6 quarters, there have been 2 quarters with identical revenue before a small jump in subsequent quarters.
I am pleased with reduced net cash outflow.
For reasons unknown to me, Morningstar are expecting only 20m revenue this year i.e. flat on Q1 but their valuation is $18. The net cash outflow expected by them for this year is $28m which I think we are on track for.
Overall, to me these are good results provided there is a pick up in revenue for the next quarter.
Mid term, the most important thing is to get reimbursement for out of hospital patients as that tripes current TAM.
- Forums
- ASX - By Stock
- AVH
- Ann: Preliminary Fiscal Second Quarter 2021 Results
Ann: Preliminary Fiscal Second Quarter 2021 Results, page-6
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.76 |
Change
0.130(4.94%) |
Mkt cap ! $187.9M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $1.044M | 382.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 980 | $2.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.76 | 10173 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 2.780 |
3 | 2504 | 2.760 |
3 | 27000 | 2.700 |
1 | 10000 | 2.680 |
3 | 2022 | 2.630 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 6155 | 3 |
2.800 | 600 | 1 |
2.820 | 4001 | 1 |
2.830 | 5000 | 1 |
2.840 | 1322 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online